SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
QLT PhotoTherapeutics (QLTI)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1321 51 0 QLTI
Emcee:  Doug Lakin Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1271Nice steady increase in share price recently. Certainly a welcome sign.don jackson-4/1/2003
1270QLT halts tariquidar study enrolment for safety review QLTCal Gary-2/23/2003
1269QLT announces Q3 results for 2002 and reiterates guidance newswire.caAl Collard-10/22/2002
1268lol if you are still long! major lol!!Brasco One-10/21/2002
1267<b>QLT and Novartis Ophthalmics launch phase III program to treat skin canAl Collard-10/11/2002
1266QLT stock climbs on FDA ruling Leonard Zehr Shares of drug developer QLT Inc. Ian@SI-10/4/2002
1265QLT Receives FDA fast track status for Tariquidar VANCOUVER, Oct. 3 /CNW/ -Al Collard-10/3/2002
1264cool... thanks fer postin' 'datDavy Crockett-9/24/2002
1263>>VANCOUVER, Sept. 24 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI - Netuck-9/24/2002
1262QLT Announces Favorable Court Decision in Massachussets Eye and Ear InfirmaryIan@SI-9/24/2002
1261Works fer me in QLT @ 13.07...Davy Crockett-8/28/2002
1260Reuters Company News EU grants wider approval for Novartis' Visudyne WedneSultan-8/28/2002
1259FIDO behind some of the sell pressure: >>BOSTON -(Dow Jones)- Certain funtuck-8/21/2002
1258QLTI has been steadily going down last few weeks, months.. Some research posted Sultan-8/19/2002
1257Visudyne users sue U.S. government Leonard Zehr A coalition of American consumIan@SI-8/7/2002
1256The WSJ Page 1 Article mentioned in today's earnings conf call. July 16, 20Ian@SI-7/25/2002
1255QLT begins pivotal phase III clinical program for multi-drug resistance in noIan@SI-6/28/2002
1254>>MONT-SAINT-HILAIRE, Quebec, June 19 /PRNewswire-FirstCall/ - Axcan Pharmtuck-6/19/2002
1253biz.yahoo.comSultan-5/31/2002
1252Ohip, the Ontario Health Insurance Plan which covers all residents of Ontario, iIan@SI-5/13/2002
1251Decaid...got the answer.. by: SPOTTEDHOOTER Long-Term Sentiment: Strong Buy 05John McCarthy-5/13/2002
1250Question to this board: I have done a fair amount of research on XR9576/TariquJohn McCarthy-5/12/2002
1249Fidelity Holds 10.28% Of QLT Inc. Common Shrs DOW JONES NEWSWIRES BOSTON -- Cemopgcw-4/18/2002
1248QLT announces Visudyne(R) sales for first quarter of 2002 Strong Visudyne SAl Collard-4/16/2002
1247<b>QLT reduces stock option request to shareholders</b> ISS/FaiAl Collard-4/11/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):